#glp1longtermsideeffects

When a weight‑loss drug promises rapid results, caregivers worry about hidden muscle loss. Semaglutide typically spares lean mass while tirzepatide may shave of

A 40% dropout rate shows semaglutide’s hidden price tag goes beyond the drug itself—physicians must weigh cost, side effects and long‑term safety. Click to see

A new study shows semaglutide can cut weight by nearly 30% compared with placebo, yet an 8% rebound risk looms. Discover why the safety profile matters before y